Biochemical and Thermochemical Conversion Processes of Lignicellulosic Biomass Fractionated Streams |
Autore | Matsakas Leonidas |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (244 p.) |
Soggetto topico | Technology: general issues |
Soggetto non controllato |
Acacia tortilis
biofuel biomass pine dust pyrolysis Napier grass bioethanol biomass fractionation enzyme hydrolysis acid pretreatment alkali pretreatment microwave-assisted pretreatment pretreatment parameters enzymatic hydrolysis glucose xylose lignocellulosic sugars microbial lipid olive mill wastewater Cryptococcus curvatus Lipomyces starkeyi lignin organosolv fractionation TGA 31P NMR HSQC heat treatment charcoal electrical resistivity coal coke high-temperature treatment organosolv Kraft lignin etherification lignin functionalization thermoplastics oxidative lignin upgrade catalytic lignin oxidation vanadate molybdate ionosolv biomimetic bio-based reductant ferroalloy industry kiln 2nd generation sugars lignocellulose hydrolyzate biorefinery furfural hydroxymethylfurfural bioeconomy life cycle assessment sustainable biomass growth mining metallurgical coke |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557406703321 |
Matsakas Leonidas
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Looking Forward to the Future of Heparin: New Sources, Developments and Applications |
Autore | Fareed Jawed |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2018 |
Descrizione fisica | 1 electronic resource (282 p.) |
Soggetto non controllato |
alginate
edema Heparin Red solid lipid nanoparticles Fe3O4·DA-BSA/HA dermatan sulfate sulfated alginate porcine heparin theranostics low-molecular-weight heparin Arixtra® biomaterials hepcidin ovarian cancer iron oxide nanoparticles heparin-induced thrombocytopenia bone morphogenetic protein (BMP) hyaluronic acid (HA) crude heparin platelets resistance sclerostin LMWH gremlin low molecular weight heparin (LMWH) low molecular weight glycosaminoglycans human plasma single crystal X-ray structure iron homeostasis noggin super paramagnetic iron oxide nanoparticles (SPION) manufacturing methods paclitaxel (PTX) brain injury bovine heparin inflammation qNMR antithrombin reference standard quantitative NMR enoxaparin danaparoid sodium NMR GDNF orthogonal multi-analytical methods ternary complex heparan sulphate serglycin bovine serum albumin (BSA) HSQC recombinant expression heparin heparin oligosaccharides functional assay BMP antagonists intestinal lymphatic absorption size exclusion chromatography heparin coating diagnosis bioreactor anemia proteoglycan heparin process PCA chemometric fluorescent probe pharmacopeia affinity chromatography component quantitative analysis Fondaparinux sodium perylene diimide dyes thrombin inhibition extended physicochemical characterization cisplatin glycosaminoglycans TGF-? chondroitin sulfate dalteparin sequence and compositional investigations molecular weight magnetic resonance imaging (MRI) industrial LC-MS iduronic acid conformation heparan sulfate growth and differentiation factor (GDF) assay subarachnoid hemorrhage |
ISBN | 3-03842-950-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Looking Forward to the Future of Heparin |
Record Nr. | UNINA-9910346841803321 |
Fareed Jawed
![]() |
||
MDPI - Multidisciplinary Digital Publishing Institute, 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|